Efecient

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Efecient

This section provides a definitive overview of Efecient (Sodium Ferric Gluconate Complex), focusing strictly on its identity, composition, and general purpose as a pharmaceutical product.

Property Description
Active ingredient Sodium Ferric Gluconate Complex (SFGC)
Form Solution for intravenous administration (Injection)
Pharmacological class Parenteral Iron Replacement Product
General therapeutic purpose Restoring total body iron stores
Origin Semisynthetic

What Type of Medicine is Efecient?

Efecient is a prescription-only injectable medicine classified as a parenteral iron replacement product, primarily used to correct iron deficiency. It belongs to the high-level therapeutic class of antianemic agents. Its official active ingredient, Sodium Ferric Gluconate Complex (SFGC), is administered through the intravenous route as a sterile solution for administration. This formulation is clinically recognized for its rapid repletion efficacy, and is typically reserved for adults who cannot tolerate or adequately absorb oral iron supplements, representing a specialized treatment approach. As a complex coordination compound, it is regarded as a semisynthetic pharmaceutical product.


Understanding the Sodium Ferric Gluconate Complex (SFGC)

The core of Efecient is the Sodium Ferric Gluconate Complex, a stable macromolecular structure containing ferric iron (Fe^3+) stabilized by a gluconate moiety. This single-ingredient product is presented as an aqueous solution designed specifically for injection. The compound's unique structure is engineered to protect the iron until it can be safely and efficiently bound by the body's iron transport proteins, allowing for controlled delivery. Pharmacological studies confirm this structure promotes efficient transfer into the body's iron pool. The complex itself is composed of iron oxide hydrate bonded to sucrose and chelated with a gluconate moiety.


General Therapeutic Goal of Iron Repletion

The primary goal of using Efecient is to achieve rapid and complete repletion of the total body iron content, which is essential for normal hemoglobin synthesis. Iron is a critical mineral required for producing hemoglobin, the protein in red blood cells that maintains oxygen transport throughout the body. By providing this iron source directly to the bloodstream, the medicine overcomes barriers to oral absorption, ensuring the necessary mineral is available to address iron deficiency and support vital physiological processes. This method is typically employed in situations requiring prompt iron restoration, such as managing iron deficiency associated with chronic conditions, supporting the body’s ability to sustain adequate oxygen transport capacity.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Efecient?

Possible side effects and safety information

The safety profile of Efecient (Sodium Ferric Gluconate Complex) is defined by officially documented adverse reactions classified by frequency and body system, as established in government regulatory labeling. The most prominent concerns relate to acute systemic risks and hypersensitivity.

Serious Adverse Reactions and Key Safety Constraints

Regulatory documents emphasize the potential for serious hypersensitivity reactions, including anaphylactic-type reactions, which have been reported as life-threatening, along with clinically significant hypotension (low blood pressure). The possibility of iatrogenic hemosiderosis (iron overload) exists with excessive parenteral iron administration. The product is contraindicated in patients with known hypersensitivity to the complex, evidence of iron overload, or anemias not caused by iron deficiency.

Frequency and System-Organ Effects

The most commonly reported adverse reactions (ge 10% incidence) include gastrointestinal effects like nausea, vomiting, and diarrhea, as well as cardiovascular effects such as hypotension and hypertension, and injection site reactions.

Less frequent, but common (5–10%), adverse effects include asthenia, headache, and fever. Adverse reactions are grouped across system-organ classes, including the Nervous System, Musculoskeletal System, and Metabolic/Nutritional Disorders, as detailed in the official prescribing information.

Population and Time-Related Safety Notes

Specific safety considerations are noted for patient populations. For instance, the safety and effectiveness have not been established in children younger than six years of age. Due to the risk of fetal distress (e.g., fetal bradycardia), use during pregnancy is advised only in the second or third trimester when the benefits outweigh the risks.

Official labeling requires monitoring patients for signs of hypersensitivity for at least 30 minutes following administration, reflecting the acute nature of potential safety events.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information regarding overexposure to Efecient (Sodium Ferric Gluconate Complex) outlines two primary risk categories: acute systemic reactions and chronic iron accumulation.

Documented Manifestations and Severe Outcomes

Acute overexposure may lead to severe, life-threatening outcomes, including shock, collapse, and generalized seizures. The most common severe reaction associated with acute administration is clinically significant hypotension (low blood pressure).

Manifestations of overdose or rapid administration documented in regulatory labels include nausea, vomiting, dizziness, loss of consciousness, dyspnea (trouble breathing), and severe lower back pain. Excessive chronic therapy carries the risk of Iron Overload (Iatrogenic Hemosiderosis).

When Immediate Medical Help is Required

Immediate emergency medical attention is required for the treatment of severe systemic reactions. Regulatory guidance explicitly mandates calling emergency services (such as 911 or equivalent) if an individual collapses, has a seizure, develops severe trouble breathing, or becomes unconscious. The Poison Control Helpline should also be contacted for specific guidance.

Management of acute overdose is symptomatic and supportive. There is no specific antidote for acute overexposure known or listed in official documentation; however, measures such as volume expansion may be used to manage significant hypotension. Monitoring for signs of severe hypersensitivity is required during and for at least 30 minutes following administration.

Therapeutic Uses of Efecient

What Efecient Treats: Main Uses and Benefits

Efecient is primarily used for symptomatic support across conditions involving acute or disruptive episodes. This class of medication is relevant when short-term assistance is needed to address discomfort and systemic imbalance. It helps manage symptom clusters that may appear suddenly or intensify temporarily.

It is applied across domains where additional support is needed for symptoms related to physical discomfort, heightened physiological activity, or noticeable physiological strain that interferes with daily functioning. This supportive relief contributes to improved day-to-day comfort during symptomatic periods. The key therapeutic benefit is assisting patients with coping more steadily with symptom fluctuations and difficult episodes.

Quick Fact: Relief for Symptom Clusters

Efecient is commonly used for symptom clusters that lead to temporary functional strain.

Regulatory References

  1. https://medlineplus.gov/druginfo/meds/a681004.html

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Efecient — Official Regulatory Information

Eligibility Scope

Classification Official Regulatory Statement
Populations for whom use is allowed Adult patients and pediatric patients age 6 years and older with Iron Deficiency Anemia (IDA) who have Chronic Kidney Disease (CKD) and are receiving hemodialysis and supplemental epoetin therapy.
Populations for whom use is contraindicated Patients with known hypersensitivity to the drug or any component, including benzyl alcohol. Patients with evidence of iron overload (e.g., hemochromatosis) or anemias not associated with iron deficiency.
Age-related eligibility rules Use is not approved for children younger than 6 years of age. It is prohibited for use in neonates and infants due to the risk of Benzyl Alcohol Toxicity.
Pregnancy and lactation eligibility status Pregnancy: Use only if clearly needed due to the potential risk of hypersensitivity reactions. Lactation: Use is not recommended when breastfeeding.

Eligibility Classifications (High-Level)

Classification Official Regulatory Status/Wording
Eligibility severity classification Contraindicated (hypersensitivity, iron overload); Not Approved (children <6 years); Prohibited (neonates/infants); Not Recommended (lactation).
Regulatory basis FDA and National Authority Prescribing Information.
Eligibility-context constraints Specific IDA/CKD/Hemodialysis status defines the approved patient population.

Resulting Eligibility Structure

Official eligibility statements:

  • Use is restricted to a specific population with IDA associated with CKD and hemodialysis.
  • The drug is contraindicated in patients with iron overload and known hypersensitivity.
  • Use is prohibited in neonates and infants and not approved for children under 6 years.
  • Use in pregnancy is permitted only if clearly needed, and lactation is not recommended.

Connection to the overall eligibility profile Official regulatory documents strictly define eligibility by limiting use to a narrow population of patients (age geq 6 years) with IDA in the context of CKD on hemodialysis. This profile imposes mandatory exclusions based on iron status and hypersensitivity and implements age-related prohibitions due to a component in the formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Sodium Ferric Gluconate Complex (Efecient) establishes interactions primarily based on administration constraints and pharmacodynamic effects, not complex metabolic pathways. The official labeling explicitly notes that formal pharmacokinetic drug-drug interactions have not been documented.

Restrictions and Incompatibilities

The medicine must not be mixed with any other medicinal products or added to total parenteral nutrition (TPN) solutions intended for intravenous infusion. This is a mandatory administration restriction due to documented physical incompatibility. The medicine is also formally contraindicated in patients with established iron overload (such as Hemosiderosis) and in individuals with known hypersensitivity to the drug or any of its components.

Pharmacodynamic Interaction Effects

Co-administration with oral iron preparations may lead to a reduction in the absorption of the oral iron product, thereby altering its exposure profile. An additive pharmacodynamic effect may also occur with medications associated with hypotension (low blood pressure), which could increase the risk or severity of that effect. For pregnant women in the second and third trimesters, severe adverse reactions experienced by the mother may cause fetal bradycardia.

Mechanism of Action

How Efecient Works

The mechanism involves a highly regulated, multi-stage pharmacodynamic cascade centered on iron delivery and metabolism.


Controlled Delivery by Macrophage Processing

The cascade begins with the Sodium Ferric Gluconate Complex (SFGC) targeting the Reticuloendothelial System (RES) macrophages for endocytosis. Inside these specialized cells, the complex is cleaved, releasing ferric iron ( Fe^3+) into a regulated environment. This controlled processing pattern results in the sustained binding of iron to transferrin, limiting the formation of Non-Transferrin Bound Iron (NTBI) in the plasma.


Integration into Transport and Storage Pools

Upon regulated release from the macrophage, the iron is immediately shuttled to two essential destinations: it is bound to the transport protein transferrin for circulation and integrated into the storage protein ferritin to replenish bodily reserves. This integration process provides the mineral for immediate use and storage, contributing to the regulation of the body's iron homeostasis.


Substrate Supply for Hemoglobin Synthesis

The transferrin delivers the iron to the bone marrow, where it acts as the necessary rate-limiting substrate for the erythropoiesis pathway, supporting the synthesis of hemoglobin. The resulting integration of iron into hemoglobin is the core physiological consequence, supporting the overall oxygen transport capacity of the blood.

Dosage and Administration Information

How to Use Efecient: Official Administration Guidelines

Efecient (Sodium Ferric Gluconate Complex) is a prescription-only solution administered exclusively through the intravenous (IV) route in a medically supervised setting, according to regulatory standards. Its usage pattern is determined by official dosing and administration rules rather than patient self-administration.

Standard Administration and Dosage

The medicine is typically administered on a scheduled, intermittent basis, usually three times per week, coinciding with hemodialysis sessions.

Feature Official Administration Guideline
Standard Adult Dose 125 mg of elemental iron per session.
Total Course Dose A full course delivers a cumulative total of 1,000 mg of elemental iron.
Pediatric Dosing For patients aged 6 to 15, the dose is 1.5 mg/kg of elemental iron per session, not to exceed 125 mg.

Preparation and Procedural Rules

Before administration as an IV infusion, the concentrated solution must undergo mandatory dilution. The standard 125 mg adult dose is diluted in 100 mL of 0.9% sodium chloride solution. The infusion must then be administered slowly over a minimum duration of 60 minutes (one hour). If given as an undiluted slow intravenous injection, the administration rate must not exceed 12.5 mg per minute. A key procedural restriction is that Efecient must not be mixed with other medications or parenteral nutrition solutions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Efecient


Evidence for Use in Iron Deficiency Anemia in Chronic Kidney Disease (CKD)

The research on Efecient (Sodium Ferric Gluconate Complex) for people with Chronic Kidney Disease (CKD) who are on hemodialysis is based primarily on several Randomized Controlled Trials (RCTs). These types of studies monitor groups of patients who receive the medicine and groups who receive a comparison treatment or placebo. Long-term surveillance studies, which monitor patients over many months, have also been used.

These studies monitored specific measurements to see how they evolved in the observed populations. Researchers primarily measured changes in levels of Hemoglobin and Hematocrit, and monitored iron-related biomarkers like Serum Ferritin and Transferrin Saturation (TSAT) to observe patterns in stable iron status. The research describes patterns related to these levels in the observed populations of adult and pediatric patients with CKD who are receiving hemodialysis. The studies often reported on how the compound behaved when it was administered along with epoetin, a drug frequently used for this population.


Evidence for Use in General Iron Deficiency

Research exploring Efecient's use in general iron deficiency includes studies designed to track how the compound moves through the body (Pharmacokinetic, or PK, studies), as well as short-term administration trials. These trials monitored short-term patterns in iron status. Studies monitored levels of Hemoglobin, Hematocrit, and iron biomarkers like Ferritin over brief, defined time intervals. The research describes patterns related to these levels in the observed populations, providing insight into short-term changes in iron availability for both iron-deficient adults and some hospitalized pediatric patients.

Long-term outcomes are not fully established. The follow-up durations were short, and the durability of the changes in iron status are not fully established. Some research was conducted in otherwise healthy, iron-deficient individuals, and the results apply only to the populations studied, meaning data for certain groups remain insufficient.


What is Still Uncertain About Efecient Research

Sample sizes were modest in some key research, such as the studies related to Acute Heart Failure (HF), where certainty remains low. Furthermore, the findings were mixed, or the sample sizes were modest for some research scenarios. Long-term effects are not fully established across all research areas, as follow-up durations were limited in many of the initial trials.

Key Studies & References Ferric gluconate complex - Drug Information (MedlinePlus Drug Information)

Frequently Asked Questions (FAQ)

Common questions about Efecient (FAQ)

Q: How quickly does Efecient typically start working?

A: Efecient's main purpose is to replenish the body’s iron stores, a process that helps support the production of hemoglobin. Clinical studies monitored short-term patterns in iron-related biomarkers (like ferritin and hemoglobin) to observe treatment response. Official documents, however, do not provide a specific timeline for when a person may begin to feel the effects of this change.

Q: What happens if I miss a dose of Efecient?

A: Efecient is administered intravenously (into the vein) on a scheduled, intermittent basis by healthcare professionals during regular hemodialysis sessions. This is not a medicine that patients administer themselves daily. Any variation from the scheduled treatment is addressed according to the protocol established by the facility administering the medicine.

Q: Does Efecient have known interactions with common over-the-counter pain relievers?

A: Regulatory documents indicate that formal pharmacokinetic drug-drug interactions, which typically involve changes in how the body processes medicines, are generally not documented for Efecient. The most notable documented interaction is that taking Efecient may reduce the absorption of oral iron preparations if used at the same time.

Q: Is it important to check my liver function while on Efecient?

A: Official product information emphasizes the need for regular monitoring of a patient’s hematologic and iron parameters (such as hemoglobin, ferritin, and transferrin saturation). It is noted that patients with existing liver disease should receive the medicine with caution. The necessary lab work for monitoring is determined through the clinical process.

Q: Does Efecient interact with common foods like grapefruit?

A: No. Efecient is administered directly into the vein (intravenously) and completely bypasses the digestive system. Therefore, interactions with common foods, such as those that occur with oral medications like grapefruit, are not a concern and are not listed in the official safety information.

Q: How does the body eliminate Efecient?

A: The medicine is a complex designed to deliver iron. The iron component is processed by specialized cells and then immediately integrated into the body’s natural storage and transport proteins (ferritin and transferrin). The remainder of the complex is cleared from the bloodstream, following the body's natural waste management pathways for IV medicines.

Q: Are there any vitamins or supplements that interact with Efecient?

A: The primary interaction noted in official documents is with oral iron preparations (supplements containing iron), which Efecient can reduce the absorption of. Apart from this, formal drug-drug interactions with vitamins or general supplements are generally not documented in the regulatory labeling.

Q: Does Efecient cause fatigue or drowsiness?

A: Official safety data reports that fatigue and asthenia (weakness or lack of energy) are common adverse reactions, occurring in 5% to 10% of patients in trials. Somnolence (drowsiness) has also been reported as an adverse reaction affecting the nervous system.

Q: Can Efecient affect concentration or focus?

A: Official safety information notes that the medicine has been associated with adverse effects grouped under the Nervous System, such as dizziness. In rare postmarketing reports, loss of consciousness has been reported. Monitoring and assessment of overall health is conducted as part of the treatment protocol.

Q: Can Efecient be taken with food, or does it need to be taken on an empty stomach?

A: Efecient is administered directly into the vein (intravenously), bypassing the stomach and digestive tract entirely. Therefore, whether the stomach is empty or if you have recently eaten is not a relevant factor for its administration or effectiveness.

Q: Is Efecient considered a long-term treatment or a short-term one?

A: Efecient is indicated for iron deficiency anemia in adults with chronic kidney disease who are receiving maintenance hemodialysis. While a single course is defined by a total cumulative dose, therapy may be repeated or continued for as long as a patient is undergoing maintenance hemodialysis, suggesting its use in a chronic care setting.

Q: Are there any major diet restrictions while taking Efecient?

A: Official regulatory documents do not list any major restrictions on general diet or food intake while receiving Efecient. The focus of documented interactions is on certain medications and supplements, especially those containing oral iron.

Q: Is it common to feel worse before feeling better on Efecient?

A: Official documents do not describe a specific pattern of 'feeling worse before feeling better.' However, many adverse reactions like headache, nausea, or dizziness may occur, and these can sometimes be more noticeable early in the treatment course. The success of treatment is measured by improvements in iron biomarkers.

Q: What should I do if I notice a change in my appetite after starting Efecient?

A: Anorexia (loss of appetite) has been reported as an adverse reaction in official safety documents. This FAQ cannot provide guidance on personal health actions; any change in appetite is addressed through the clinical process with the healthcare provider overseeing the treatment.

Q: Is Efecient an antibiotic?

A: No. Efecient is classified as a parenteral iron replacement product and an antianemic agent. It is a medicine that helps restore the body’s iron levels and is not used to treat bacterial infections like an antibiotic.

Q: Is Efecient a controlled substance?

A: No. While Efecient is a prescription-only medicine that must be administered under medical supervision, it is not scheduled under the US Controlled Substances Act (CSA) and is therefore not considered a controlled substance.

Q: Is it possible to develop a tolerance to Efecient over time?

A: Official regulatory documents do not describe the development of drug tolerance to Efecient. As an iron replacement product, its function is to provide the body with a necessary physiological substrate (iron) to support blood production.

Q: Can I drink alcohol while taking Efecient?

A: Official documents do not contain a formal restriction or warning against consuming alcohol while receiving Efecient. However, the medicine has a documented adverse effect of hypotension (low blood pressure), and alcohol may independently increase the risk of dizziness or lightheadedness.

Q: What if Efecient doesn't seem to be working for me after a few weeks?

A: The effectiveness of treatment is formally monitored through regular laboratory tests that check iron-related biomarkers and hemoglobin levels in the blood. If expected progress in clinical measurements is not observed after the initial weeks, lack of observed progress in clinical measurements is addressed through the ongoing clinical process.

Q: Do most people take Efecient at the same time every day?

A: No. Efecient is typically administered on a scheduled, intermittent basis, often three times per week. The timing of administration is fixed to coincide with the patient’s standing hemodialysis session schedule, not a daily routine that the patient sets.

Q: Is there a generic version of Efecient available?

A: Yes. Efecient is the brand name for the generic compound Sodium Ferric Gluconate Complex. The generic form of this medicine is available for use in clinical practice.

Q: Is Efecient known to cause weight changes?

A: Official safety documentation notes that weight gain and unusual weight gain or loss have been reported as adverse reactions. However, these effects are not listed among the most commonly reported side effects.

Q: Are there different forms of Efecient (e.g., tablet, liquid)?

A: No. Efecient is only manufactured and approved as a sterile solution for intravenous (IV) administration (injection). It is not available in any oral forms like tablets, capsules, or liquids for patient self-administration.

Q: Does Efecient cause dry mouth?

A: Dry mouth (xerostomia) has been reported as an adverse reaction associated with Efecient, according to official safety documentation. The frequency with which this occurs is not known.

Q: Is Efecient related to or derived from any natural substances?

A: Efecient is officially classified as a semisynthetic pharmaceutical product. It is an engineered complex containing ferric iron (a naturally occurring mineral) stabilized by a gluconate moiety for controlled delivery into the bloodstream.

Q: Is Efecient available in countries outside of [Example Country]?

A: Yes. Official research and labeling (such as the EMA Summary of Product Characteristics) indicate that this iron complex has been in clinical use in countries across Europe and is not restricted only to one specific country.

How should Efecient be stored and disposed of?

How to Store and Dispose of Efecient?

The storage and disposal of Efecient (Sodium Ferric Gluconate Complex) must adhere strictly to official regulatory guidelines to maintain the product's integrity and ensure safety.

Storage/Handling Requirement Official Classification/Rule
Temperature Range Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Freezing/Prohibition The product must be protected from freezing.
Visual Inspection Inspect visually for particulate matter or discoloration (precipitates); do not use if observed.
Post-Dilution Stability Use the diluted solution immediately. If immediate use is not possible, discard after four hours at room temperature.
Child Safety Keep out of the sight and reach of children.
Disposal Rule Dispose of unused product and waste material in accordance with local requirements.

All vials must be stored in their original container. As an injectable medicine, disposal of any unused solution or packaging should follow local medical waste protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Efecient found in:

A-Z Index: